News US trials of Gilead's remdesivir begin against COVID-19 coro... The first US trial of Gilead’s unapproved antiviral remdesivir has officially begun against the novel coronavirus disease COVID-19.
News Trump’s budget cuts will be disastrous for healthcare and pa... Following President Trump’s announcement of massive cuts to the National Institutes of Health funding last week, science leaders in the US and beyond have warned of dire long term consequen
News Dream of artificial pancreas closer with NIH trials Four international trials will speed development of technology
News White House pledges $300m to advance digital health, AI Money to be invested in precision medicine, brain research and the integration of AI technology.
News Neurogene drops high-dose arm in Rett study after death The patient affected by a serious adverse event in Neurogene's clinical trial of Rett syndrome gene therapy has now died
Sales & Marketing Coming soon: The Life Sciences Industry Report 2025 – insigh... Prepare for 2025 with pharmaphorum’s Life Sciences Report, featuring expert insights on AI in drug development, gene therapy, and top industry trends